Speech-Language Pathologists in Del City, OK Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Miss Mary Hebert, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 Hampton Dr, Del City, OK 73115 Phone: 405-245-6955

Ms. Cynthia A Barger-fenton, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5509 Main Street, Suite 104, Del City, OK 73115 Phone: 405-245-7376    Fax: 405-391-6035

News Archive

Daily ginger consumption reduces muscle pain caused by exercise: Researchers

For centuries, ginger root has been used as a folk remedy for a variety of ailments such as colds and upset stomachs. But now, researchers at the University of Georgia have found that daily ginger consumption also reduces muscle pain caused by exercise.

Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery

A new study helps explain changes in the intestines that may be responsible for the reversal of diabetes in people who undergo a type of bariatric surgery known as Roux-en-Y gastric bypass surgery.

Mindfulness-based cognitive therapy more beneficial without antidepressant drugs

An investigation published in the current issue of Psychotherapy and Psychosomatics indicates that mindfulness based cognitive therapy (MBCT) is most helpful when antidepressant drugs are not used.

Risk of leukaemia and brain cancer in children could be tripled by radiation exposure from CT scans

Radiation exposure received from 2 to 3 computed tomography (CT) scans of the head in childhood (aged under 15 years)—giving a cumulative dose of around 60 mGy— can triple the risk of later developing brain cancer, while around 5 to 10 such scans (cumulative dose around 50 mGy) could triple the risk of developing leukaemia (with the differing number of scans related to different absorption rates of the brain versus the bone marrow and age at time of scanning).

Praxair's 3.250% notes offering expected to close on September 1, 2009

Praxair, Inc. (NYSE:PX) has priced $400 million of 3.250% notes due September 15, 2015. The notes are being offered under its universal shelf registration statement filed with the U.S. Securities and Exchange Commission. The offering is led by Citigroup Global Markets Inc. and RBS Securities Inc.

Read more Medical News

› Verified 4 days ago